S
DXCM icon

SharpePoint’s DexCom DXCM Stock Holding History

SharpePoint’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,705
Closed -$264K – 53
2025
Q1 		$264K Sell
3,705
-700
-16% -$57.1K 0.23% 63
2024
Q4 		$343K Buy
+4,405
New +$326K 0.31% 55

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

SharpePoint's DXCM Position: Q2 2025 in Review

SharpePoint sold out of DexCom (DXCM) in Q2 2025, closing a stake of 3,705 shares — an estimated $264K sold.

SharpePoint first reported a position in DXCM in Q4 2024 and held it in 2 quarters. The position peaked at $343K in Q4 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • SharpePoint reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • SharpePoint sold 3,705 DexCom shares in Q2 2025, an estimated $264K.
  • SharpePoint first reported a position in DexCom in Q4 2024 and held it in 2 quarters.
  • SharpePoint's DexCom position peaked at $343K in Q4 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on SharpePoint's 13F filing for Q2 2025, filed 11 Aug 2025.